For Physicians

Introduction by Joseph Antin, MD

One of the major challenges in the past 40 years of stem cell transplantation has been donor availability.

Complex Case Study: Four Stem Cell Transplants for Acute Myeloid Leukemia (AML)

In 2003, a then-48-year-old woman who is an avid distance runner presented to her primary care physician after noticing unusual fatigue during a 10-kilometer race.

Complex Case Study: The Patient's Perspective

While running the Saint Patrick's Road Race on March 22, 2003, near my home in western Massachusetts, I could hardly catch my breath.

Clinical Practice Spotlight: Management of Graft-versus-Host Disease (GVHD)

Risk factors for GVHD include greater degree of HLA mismatch between donor and recipient; stem cell source (the risk of GVHD with peripheral blood stem cells is greater than with bone marrow stem cells, which is, in turn, greater than with umbilical cord blood); gender mismatch with the donor; multiparity of a female donor; and more intensive conditioning regimens.

Research Spotlight: Transformation of Hematopoietic Cell Transplantation from Stem to Stern

For patients with active, advanced acute myeloid leukemia (AML) and chronic lymphoid leukemia (CLL) who are undergoing HSCT...

Clinical Trial Spotlight: Bortezomib-Based GVHD Prophylaxis

Allogeneic hematopoietic stem cell transplantation (HSCT) represents a potentially curative option for patients with advanced or aggressive hematologic malignancies.

Hematologic Malignancies: Physician Resources

If you are a clinician specializing in the field of hematologic oncology, we can help you refer a patient, explore open clinical trials, learn about CME events, and more.

View our full list of hematologic malignancies resources for referring providers.